- Report
- March 2025
- 1048 Pages
Global
From €4265EUR$4,799USD£3,723GBP
- Report
- October 2025
- 199 Pages
Global
From €3151EUR$3,545USD£2,751GBP
€3501EUR$3,939USD£3,056GBP
- Drug Pipelines
- July 2025
- 280 Pages
Global
From €2133EUR$2,400USD£1,862GBP
€2666EUR$3,000USD£2,328GBP
- Report
- November 2025
- 183 Pages
Global
From €3999EUR$4,500USD£3,491GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1422EUR$1,600USD£1,241GBP
€1778EUR$2,000USD£1,552GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- August 2025
- 194 Pages
Global
From €3151EUR$3,545USD£2,751GBP
€3501EUR$3,939USD£3,056GBP
- Report
- September 2025
- 250 Pages
Global
From €3991EUR$4,490USD£3,484GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1422EUR$1,600USD£1,241GBP
€1778EUR$2,000USD£1,552GBP
- Report
- September 2025
- 250 Pages
Global
From €3991EUR$4,490USD£3,484GBP
- Report
- September 2025
- 250 Pages
Global
From €3991EUR$4,490USD£3,484GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1422EUR$1,600USD£1,241GBP
€1778EUR$2,000USD£1,552GBP
- Report
- December 2024
- 332 Pages
Global
From €3730EUR$4,197USD£3,256GBP
- Report
- September 2025
- 950 Pages
Global
From €4439EUR$4,995USD£3,875GBP
- Report
- May 2025
- 472 Pages
Global
From €6217EUR$6,995USD£5,427GBP
- Report
- December 2025
- 281 Pages
Global
From €6217EUR$6,995USD£5,427GBP
- Report
- October 2025
- 391 Pages
Global
From €4265EUR$4,799USD£3,723GBP
- Report
- December 2025
- 262 Pages
Global
From €6217EUR$6,995USD£5,427GBP
- Report
- February 2025
- 315 Pages
Global
From €4265EUR$4,799USD£3,723GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more